Integrity Research Ligandrol LGD-4033 – Selective Androgen Receptor Research Compound Ligandrol (LGD-4033) is a non-steroidal Selective Androgen Receptor Modulator (SARM) developed for research into anabolic signaling, muscle preservation, and bone density pathways. It has been extensively studied in laboratory and clinical research settings for its high affinity and selectivity toward androgen receptors in skeletal muscle and bone tissue. Integrity Research Ligandrol LGD-4033 is manufactured strictly for laboratory and investigational use and is intended for qualified professionals studying androgen receptor modulation and tissue-specific anabolic activity. Mechanism of Action: Androgen Receptor Selectivity Unlike anabolic steroids, LGD-4033 was designed to selectively bind androgen receptors in target tissues without significant activity in prostate or other androgen-sensitive organs. This selectivity is the core reason Ligandrol has been studied as a potential alternative to traditional anabolic agents in controlled research environments. High AR binding affinity: Demonstrates strong interaction with androgen receptors in muscle and bone. Tissue selectivity: Designed to minimize off-target androgenic activity. Anabolic signaling research: Studied for effects on lean mass and bone mineral density. Non-steroidal structure: Does not convert to estrogen or DHT. Primary Research Applications LGD-4033 has been examined in multiple research contexts where muscle preservation, strength signaling, and metabolic efficiency are of interest. Research focus centers on its ability to stimulate anabolic pathways while limiting androgenic exposure. Lean mass retention and muscle atrophy research Bone density and skeletal integrity studies Anabolic signaling pathway analysis Catabolism resistance in calorie-restricted models Comparative SARM efficacy research LGD-4033 Compared to Other SARMs In comparative research models, LGD-4033 is frequently distinguished by its potency at low concentrations and its pronounced activity in muscle and bone tissue. This has made it a reference compound in androgen receptor research. Higher anabolic signaling than mild SARMs such as Ostarine in controlled studies More targeted than non-selective androgenic agents Common benchmark compound in SARM comparison research Supplement Facts Serving Size 1 Capsule Servings Per Container 90 Ligandrol (LGD-4033) 5 mg * * Daily Value not established. Quality & Research Integrity Integrity Research Ligandrol LGD-4033 is produced with an emphasis on compound identity, consistency, and laboratory reliability. Each batch is intended to support controlled research protocols where reproducibility and precision are essential. Produced for laboratory and investigational use only Non-steroidal research compound Handled to support research accuracy and consistency Intended Use & Compliance Notice This product is intended exclusively for qualified researchers, laboratories, and institutional research settings. Not Intended For: Human consumption or self-administration Dietary supplementation or athletic enhancement Medical or veterinary use Competitive or recreational performance use Legal & Research Disclaimer FOR RESEARCH PURPOSES ONLY. This product is not approved by the FDA for human consumption, medical use, or dietary supplementation. It is not intended to diagnose, treat, cure, or prevent any disease. By purchasing this product, you acknowledge that you are a qualified professional conducting legitimate research and assume full responsibility for compliance with all applicable laws and regulations in your jurisdiction. Animal Supps makes no warranties, express or implied, regarding the safety, efficacy, or legality of this product outside of its intended research use.
